Liquidia (NASDAQ:LQDA) CEO Roger Jeffs Sells 25,000 Shares

Key Points

• CEO Roger Jeffs sold 25,000 shares on April 15 at an average price of $40.14 for about $1,003,500, reporting the trade under a pre-arranged Rule 10b5-1 plan and retaining 1,466,934 shares (a 1.68% reduction).
• Across April 9–15 he executed several additional sales totaling roughly 107,500 shares for about $4.25 million, representing substantial insider selling over the week.
• Liquidia shares traded up 3.2% to $41.40 on higher volume; the company recently beat quarterly EPS and revenue estimates (revenue +3,072% YoY) but still reports negative margins and analysts forecast -1.51 EPS for the year with a consensus target of $43.44.

Liquidia Corporation (NASDAQ:LQDA - Get Free Report) CEO Roger Jeffs sold 25,000 shares of the business's stock in a transaction that occurred on Wednesday, April 15th. The stock was sold at an average price of $40.14, for a total value of $1,003,500.00. Following the sale, the chief executive officer owned 1,466,934 shares of the company's stock, valued at approximately $58,882,730.76. This represents a 1.68% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Roger Jeffs also recently made the following trade(s):

• On Tuesday, April 14th, Roger Jeffs sold 3,300 shares of Liquidia stock. The stock was sold at an average price of $40.00, for a total value of $132,000.00.
• On Monday, April 13th, Roger Jeffs sold 32,744 shares of Liquidia stock. The stock was sold at an average price of $38.37, for a total value of $1,256,387.28.
• On Friday, April 10th, Roger Jeffs sold 21,433 shares of Liquidia stock. The shares were sold at an average price of $40.12, for a total value of $859,891.96.
• On Thursday, April 9th, Roger Jeffs sold 25,000 shares of Liquidia stock. The shares were sold at an average price of $40.12, for a total transaction of $1,003,000.00.

Liquidia Trading Up 3.2%

NASDAQ LQDA traded up $1.28 on Thursday, reaching $41.40. The company had a trading volume of 1,184,168 shares, compared to its average volume of 983,955. The company has a debt-to-equity ratio of 2.97, a current ratio of 2.01 and a quick ratio of 1.84. The firm has a market cap of $3.65 billion, a price-to-earnings ratio of -49.88 and a beta of 0.45. The business has a 50 day moving average of $36.63 and a two-hundred day moving average of $33.14. Liquidia Corporation has a fifty-two week low of $11.85 and a fifty-two week high of $46.67.

Liquidia (NASDAQ:LQDA - Get Free Report) last released its quarterly earnings data on Thursday, March 5th. The company reported $0.15 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.08 by $0.07. The company had revenue of $92.02 million for the quarter, compared to analysts' expectations of $87.49 million. Liquidia had a negative net margin of 43.53% and a negative return on equity of 209.33%. The business's revenue for the quarter was up 3072.4% compared to the same quarter last year. Analysts forecast that Liquidia Corporation will post -1.51 EPS for the current year.

Institutional Trading of Liquidia

A number of large investors have recently bought and sold shares of LQDA. Federated Hermes Inc. purchased a new position in Liquidia in the 3rd quarter valued at approximately $7,290,000. Caprock Group LLC purchased a new position in Liquidia in the 3rd quarter valued at approximately $37,114,000. Farallon Capital Management LLC grew its stake in Liquidia by 102.1% in the 3rd quarter. Farallon Capital Management LLC now owns 8,565,638 shares of the company's stock valued at $194,783,000 after buying an additional 4,326,876 shares in the last quarter. Apis Capital Advisors LLC purchased a new position in Liquidia in the 3rd quarter valued at approximately $9,569,000. Finally, Campbell & CO Investment Adviser LLC purchased a new position in Liquidia in the 3rd quarter valued at approximately $2,026,000. 64.54% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several brokerages recently weighed in on LQDA. Raymond James Financial reaffirmed a "strong-buy" rating on shares of Liquidia in a research report on Thursday, March 5th. Jefferies Financial Group raised their price target on shares of Liquidia from $45.00 to $55.00 and gave the stock a "buy" rating in a research note on Tuesday, January 13th. Oppenheimer increased their price objective on Liquidia from $16.00 to $19.00 and gave the company an "underperform" rating in a report on Thursday, March 12th. Weiss Ratings reissued a "sell (d-)" rating on shares of Liquidia in a research report on Thursday, January 22nd. Finally, BTIG Research raised their target price on Liquidia from $49.00 to $50.00 and gave the stock a "buy" rating in a research report on Thursday, March 5th. Two equities research analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating, one has given a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $43.44.

Liquidia Company Profile

Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.

The company's lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.